AzTrials
AzTrials

Tooth Extraction Site HealingEarly Phase 1BCPARPBVNCT07638358

Assessment of the Impact of Neobone® (Biphasic Calcium Phosphate) on Bone Volume in Alveolar Ridge Preservation After Tooth Extraction

A Early Phase 1 study testing Neobone® (Biphasic Calcium Phosphate) in people with Tooth Extraction Site Healing and Alveolar Ridge Preservation, run by Egas Moniz - Cooperativa de Ensino Superior, CRL at 1 site in Portugal.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this randomized clinical trial is to assess whether BCP (Biphasic Calcium Phosphate) improves alveolar ridge preservation (ARP) in patients who need tooth extraction. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
Neobone® (Biphasic Calcium Phosphate)
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 sitePortugal
Study dates
1 Dec 2025to Dec 2028
Phase
Early Phase 1
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • 18 years or older
  • Acceptance of informed consent
  • Type 1 or 2 extraction sockets (Elian et al. 2007)

Who cannot join

  • Presence of active infection or severe inflammation in the intervention zone
  • Relevant medical history that contraindicates implant surgery
  • Patients with poor oral hygiene (full-mouth plaque score and full-mouth bleeding score >15%) and lack of motivation
  • Uncontrolled diabetes (reported levels of glycated haemoglobin exceeding 7%)
  • Uncontrolled and /or untreated periodontal disease
  • Heavy smokers (more than 10 cigarettes per day)
  • Immunosuppression

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Angel Lobito, Masters' in Dentistry contact

00351924347050

alobito@egasmoniz.edu.pt

Portugal1 site, 1 recruiting
  • Clinica Dentária Egas Moniz

    Caparica, Monte Da Caparica, 2829-511

    Angel Lobito, Masters' in Dentistry, 00351924347050, alobito@egasmoniz.edu.pt

    Recruiting

Other trials in Portugal

About this study

Official title: Assessment of Safety and Performance of Neobone®: A Prospective Observational Study in the Field of Dentistry

The goal of this randomized clinical trial is to assess whether BCP (Biphasic Calcium Phosphate) improves alveolar ridge preservation (ARP) in patients who need tooth extraction. The main question it aims to answer is whether using BCP for alveolar ridge preservation has a positive effect on bone volume compared with natural healing.

The main questions it aims to answer are:

Read more

Does BCP improve ridge preservation compared with natural healing?

Researchers will compare BCP grafted sockets to natural healing sockets to see if BCP better preserves ridge volume.

Participants will:

Have a tooth indicated for extraction.

Be assigned to either BCP or natural healing.

Undergo CBCT (Cone Beam Computed Tomography) and intra-oral scanning after extraction and after six months of healing to measure horizontal and vertical resorption and bone density.

Being tested
Neobone® (Biphasic Calcium Phosphate)
Keywords
Alveolar Ridge Preservation, Biphasic Calcium Phosphate, Tooth Extraction, Volumetric Changes, Implant site development, Bone volume, Socket preservation, Ridge augmentation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Neobone® (Biphasic Calcium Phosphate)Device

    After tooth extraction the socket will be grafted with Neobone® (Biphasic Calcium Phosphate)

Study groups in NCT07638358
Study groupRoleWhat they receive
Neobone® (Biphasic Calcium Phosphate)ExperimentalAfter tooth extraction the socket will be grafted with Neobone® (Biphasic Calcium Phosphate)
Receives: Device: Neobone® (Biphasic Calcium Phosphate)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in alveolar ridge volume after tooth extraction

    Change in alveolar ridge volume after tooth extraction on sockets grafted with Biphasic Calcium Phosphate

    Measured: From enrollment to the end of treatment at 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jun 2026
  2. Study start1 Dec 2025
  3. Primary completionDec 2026 (estimated)
  4. Study completionDec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Early Phase 1
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07638358
Sponsor's protocol ID
EM1653
Acronym
BCPARPBV
Status last verified
Jun 2026
First submitted
5 Jun 2026
Last updated
11 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Mishchenko O, Yanovska A, Kosinov O, Maksymov D, Moskalenko R, Ramanavicius A, Pogorielov M. Synthetic Calcium-Phosphate Materials for Bone Grafting. Polymers (Basel). 2023 Sep 19;15(18):3822. doi: 10.3390/polym15183822.

    PubMed 37765676

Questions about this trial

What is this clinical trial studying?

A Early Phase 1 study testing Neobone® (Biphasic Calcium Phosphate) in people with Tooth Extraction Site Healing and Alveolar Ridge Preservation, run by Egas Moniz - Cooperativa de Ensino Superior, CRL at 1 site in Portugal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 11 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Early Phase 1 (sometimes called Phase 0) studies give a very small amount of a treatment to a few people, mainly to see how the body handles it.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Angel Lobito, Masters' in Dentistry (00351924347050, alobito@egasmoniz.edu.pt), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in alveolar ridge volume after tooth extraction (time frame: From enrollment to the end of treatment at 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07638358, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in